The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer-A Meta-Analysis
Purpose: Triple-negative breast cancer (TNBC) is the most dangerous subtype of breast cancer with high rates of metastasis and recurrence. The efficacy of capecitabine in chemotherapy for TNBC is still controversial. This study evaluated the efficacy and safety of capecitabine combining with standar...
Saved in:
Main Authors: | Zilin Zhang (Author), Kai Ma (Author), Jing Li (Author), Yeneng Guan (Author), Chaobo Yang (Author), Aqin Yan (Author), Hongda Zhu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer
by: Maria Fernanda Imperio Pereira, et al.
Published: (2024) -
Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers
by: Yingnan Si, et al.
Published: (2022) -
Chlorin Conjugates in Photodynamic Chemotherapy for Triple-Negative Breast Cancer
by: Meden F. Isaac-Lam
Published: (2024) -
The role of carboplatin in the neoadjuvant chemotherapy treatment of triple negative breast cancer
by: Aurelio Bartolome Castrellon, et al.
Published: (2017) -
Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
by: Alaina J. Kessler, MD, MPH, et al.
Published: (2023)